Regeneron Pharmaceuticals (REGN)

Sales/Maturities of Investments

$2.15B

Quarterly · Period ending: · USD

REGN logo

REGN Sales/Maturities of Investments

Latest reported$2.15B
REGN Quarterly Sales/Maturities of Investments ($32.30M → $2.15B)
High-resolution chart · PNG

REGN sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
2,148,600,000
2,606,500,000
2,555,000,000
3,365,000,000
2,167,900,000
3,458,300,000
2,582,000,000
4,258,600,000
4,054,500,000
4,132,200,000
2,382,900,000
2,997,800,000
2,268,700,000
1,792,800,000
1,537,400,000
1,831,700,000
1,435,100,000
746,300,000
318,000,000
680,200,000
800,800,000
416,300,000
454,700,000
486,600,000
2,402,500,000
441,200,000
297,800,000
560,500,000
407,500,000
338,400,000
131,497,000
181,891,000
206,936,000
255,276,000
165,309,000
107,109,000
153,154,000
119,012,000
82,365,000
89,914,000
41,768,000
60,409,000
61,442,000
72,226,000
113,313,000
80,456,000
259,939,000
60,628,000
73,381,000
82,469,000
58,994,000
11,908,000
252,490,000
54,754,000
178,439,000
88,889,000
96,028,000
75,853,000
101,826,000
107,899,000
158,480,000
58,151,000
46,088,000
92,604,000
73,550,000
64,359,000
12,477,000
94,211,000
108,029,000
82,694,000
203,274,000
203,734,000
107,344,000
132,509,000
163,430,000
110,020,000
140,457,000
113,262,000
44,450,000
166,457,000
30,975,000
64,317,000
37,566,000
78,202,000
52,295,000
55,385,000
31,565,000
149,362,000
20,267,000
76,715,000
35,856,000
69,655,000
54,915,000
92,889,000
85,366,000
48,432,000
37,215,000
44,818,000
46,978,000
25,046,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.